Pan, B.; Yang, X.; Wang, X.; Fang, J.; Liu, Q.; Zou, N.; Xia, C.; Shang, H.
AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer. Pharmaceutics 2026, 18, 257.
https://doi.org/10.3390/pharmaceutics18020257
AMA Style
Pan B, Yang X, Wang X, Fang J, Liu Q, Zou N, Xia C, Shang H.
AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer. Pharmaceutics. 2026; 18(2):257.
https://doi.org/10.3390/pharmaceutics18020257
Chicago/Turabian Style
Pan, Botao, Xiujuan Yang, Xuanji Wang, Jiahao Fang, Qingqing Liu, Ning Zou, Chenglai Xia, and Huiling Shang.
2026. "AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer" Pharmaceutics 18, no. 2: 257.
https://doi.org/10.3390/pharmaceutics18020257
APA Style
Pan, B., Yang, X., Wang, X., Fang, J., Liu, Q., Zou, N., Xia, C., & Shang, H.
(2026). AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer. Pharmaceutics, 18(2), 257.
https://doi.org/10.3390/pharmaceutics18020257